SUBSCRIBE
SUBSCRIBE
Genetown

AlphaMed Pharmaceuticals Awarded $750,000 Grant for Its Targeted Melanoma Therapy

May 7, 2008 | 
1 min read

ACTON, Mass.--(BUSINESS WIRE)--AlphaMed Inc. has been awarded a $750,000 peer review grant from the National Cancer Institute to continue development of its targeted melanoma therapy.

MORE ON THIS TOPIC
Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
June 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Collage of Sarepta Therapeutics, DNA, and an IV bag
FDA
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
May 7, 2024
 · 
4 min read
 · 
Tyler Patchen